Stability Indicating RP-HPLC Method Development and Validation for the determination of Pretomanid an anti-bacterial drug
暂无分享,去创建一个
[1] Muddukrishna Badamane Sathyanarayana,et al. Stability Indicating Assay Method Development and Validation for Simultaneous Estimation of Ofloxacin and Ornidazole by RP-HPLC in Bulk: An Application to Tablet Formulation and Dissolution Studies , 2021, Indian Journal of Pharmaceutical Education and Research.
[2] P. Řezanka,et al. Insight into the formation of N-nitrosodimethylamine in metformin products. , 2020, Journal of pharmaceutical and biomedical analysis.
[3] R. Kakde,et al. Stability-indicating method development and validation for estimation of clopidogrel bisulfate in pharmaceutical dosage form by reverse-phase high-performance liquid chromatography , 2020 .
[4] M. Goud,et al. Stability indicating high performance liquid chromatography method development and validation for simultaneous estimation of Glecaprevir and Pibrentasvir in bulk and pharmaceutical dosage form , 2020 .
[5] G. Pant,et al. RP-HPLC method development and validation for bedaquiline fumarate to evaluate its forced degradation behaviour and stability in official dissolution media , 2020, Future Journal of Pharmaceutical Sciences.
[6] B. Sowmya,et al. Stability Indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Tezacaftor and Ivacaftor in Bulk and Pharmaceutical Dosage Form , 2020, Asian Journal of Pharmaceutical Analysis.
[7] D. Rawat,et al. An overview of new antitubercular drugs, drug candidates, and their targets , 2020, Medicinal research reviews.
[8] P. Mondal,et al. A New Stability Indicating Validated RP-HPLC Method for Simultaneous Estimation of Escitalopram and Clonazepam in Bulk and Tablet Dosage Form , 2019, Asian Journal of Pharmaceutical Analysis.
[9] D. Sharmila,et al. Stability Indicating RP-HPLC Method for Estimation of Pantoprazole and Ondansetron in Pharmaceutical Dosage Form , 2019, International Journal of Pharma Research and Health Sciences.
[10] M. Mohite,et al. Validation of Stability Indicating RP-HPLC, Method of Analysis for assay of Ivabradine HCl in SR Tablet , 2019, Asian Journal of Pharmaceutical Analysis.
[11] S. Kshirsagar,et al. Development and Validation of HPLC Method for Estimation of Pharmaceutical Drug and its Stability Studies in Simulated Biological Fluid: Comparative Study , 2019, Asian Journal of Pharmacy and Technology.
[12] FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs , 2019, Case Medical Research.
[13] L. R. Ingole. Development of Stability Indicating RP-HPLC Method for Estimation of Clemastine Fumarate and its Pharmaceutical Dosage Form , 2019, Research Journal of Pharmaceutical Dosage Forms and Technology.
[14] N. Fotouhi,et al. Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis , 2019, Antimicrobial Agents and Chemotherapy.
[15] Chandrasekhar Kothapalli Bonnoth,et al. A Novel Stability Indicating RP-HPLC Assay Method Development and Validation for the Quantification of Cyamemazine Tartrate in bulk and its Pharmaceutical Dosage Form , 2018 .
[16] M. Lyons. Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients , 2018, Antimicrobial Agents and Chemotherapy.
[17] M. Beckmann,et al. Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824) , 2018, Scientific Reports.
[18] Yong-Soo Kwon. Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis , 2017, Chonnam medical journal.
[19] B. Bhavya,et al. Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Albendazole and Ivermectin in Pharmaceutical Dosage form , 2017 .
[20] Shyamal C. Das,et al. Simultaneous HPLC assay for pretomanid (PA‐824), moxifloxacin and pyrazinamide in an inhaler formulation for drug‐resistant tuberculosis , 2017, Journal of pharmaceutical and biomedical analysis.
[21] Yetao Ma,et al. Pharmacokinetics and tissue distribution study of PA-824 in rats by LC-MS/MS. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[22] T. Govender,et al. Determination of the antitubercular drug PA-824 in rat plasma, lung and brain tissues by liquid chromatography tandem mass spectrometry: application to a pharmacokinetic study. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[23] Shengyong Zhang,et al. LC-MS/MS method for the simultaneous determination of PA-824, moxifloxacin and pyrazinamide in rat plasma and its application to pharmacokinetic study. , 2014, Journal of pharmaceutical and biomedical analysis.
[24] K. Dooley,et al. Phase I Safety, Pharmacokinetics, and Pharmacogenetics Study of the Antituberculosis Drug PA-824 with Concomitant Lopinavir-Ritonavir, Efavirenz, or Rifampin , 2014, Antimicrobial Agents and Chemotherapy.
[25] Y. Agrawal,et al. Development of forced degradation and stability indicating studies of drugs—A review , 2013, Journal of pharmaceutical analysis.
[26] A. Rustum,et al. Efficient method development strategy for challenging separation of pharmaceutical molecules using advanced chromatographic technologies. , 2007, Journal of chromatography. A.
[27] Robert C. Reynolds,et al. Preclinical Testing of the Nitroimidazopyran PA-824 for Activity against Mycobacterium tuberculosis in a Series of In Vitro and In Vivo Models , 2005, Antimicrobial Agents and Chemotherapy.
[28] A. Nayak,et al. Development of validated analytical methods and stability indicating studies for pharmaceutical formulation , 2021, Asian Journal of Pharmaceutical Analysis.
[29] S. Kshirsagar,et al. Development and Validation of Analytical Method by RP-HPLC and Forced Degradation Studies of Tioconazole Drug , 2019, Asian Journal of Pharmaceutical Analysis.
[30] J. Wahlich,et al. A practical approach to method validation in pharmaceutical analysis. , 1990, Journal of pharmaceutical and biomedical analysis.